Bevacizumab Treatment For Type 1 ROP

NCT04634578 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Retinopathy of Prematurity

Interventions

DRUG: Bevacizumab

Sponsor

Jaeb Center for Health Research

Collaborators

[object Object]
[object Object]